Rodrigo Ruiz Soto
Technik-/Wissenschafts-/F&E-Leiter bei DECIPHERA PHARMACEUTICALS, INC.
Profil
Rodrigo Ruiz Soto is currently a Senior Director-Medical at ImmunoGen, Inc. and a Senior Vice President-Clinical Development at Deciphera Pharmaceuticals, Inc. He previously worked as a Medical Director at Sanofi, Inc. He holds a doctorate degree from Universidad Nacional Autónoma de México.
Aktive Positionen von Rodrigo Ruiz Soto
| Unternehmen | Position | Beginn |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
| IMMUNOGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Rodrigo Ruiz Soto
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rodrigo Ruiz Soto
| Universidad Nacional Autónoma de México | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
